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Abstract 
Thalassemia minor is known to be a hereditary disease involving affected globin chains. In Thalassemia minor, the fetus inherits 
haemoglobin genes during fertilization, each from the mother and the father, respectively. Individuals with a defect in one gene are 
known as carriers of Thalassemia minor. There are different procedures available for the detection of Thalassemia minor but most 
of them are expensive, so a study was designed at Microbiology department of Jinnah University for Women to check the total RBC 
count of known Thalassemia minor patients. In this study, one hundred (100) blood samples of known Thalassemia minor 
individuals were collected. The results showed increased levels of red cell count in Thalassemia minor patients as compared to the 
controls (normal persons) which were correlated with naked-eye single tube Red cell osmotic fragility test (NESTROFT). The results 
were further confirmed by the evaluation of red cell indices by complete blood count test. Thalassemia minor patients have 
hypochromic microcytic red blood cells with increased red blood cell number and they may have mild anemia but are usually 
asymptomatic. The main purpose of this study is to give awareness to our community about Thalassemia minor and its cheap 
diagnosis which can differentiate it from other types of anemia. 
Keywords: Thalassemia, heterozygous, microcytosis, anemia. 
 
To cite this article:  Hamid, M., Nawaz, B., Afshan, N., 2016. Significance of Red Cell Count for the Detection of Thalassemia 
Minor. PSM Biol. Res., 01(1): 22-25. 
 
INTRODUCTION 
Thalassemia minor is said to be a monogenetic blood 
condition. Thalassemia minor patients are usually 
asymptomatic and lead a good life (Rachmilewitz and 
Giardina, 2011). A child develops Thalassemia minor when 
he/she inherits the defected gene from one of the parents, 
or a more severe form of Thalassemia (Thalassemia major) 
if the gene from both the parents has been inherited. The 
term “Thalassemia” actually covers a large group of 
inherited blood diseases which can be found commonly 
among people of Mediterranean and Asian origin. 
Individuals carrying Thalassemia have defects in the genes 
interfering with the haemoglobin production and ultimately 
that individual developsanemia. The most common among 
the subgroups of Thalassemia minor is Beta-Thalassemia 
minor. Beta-Thalassemia minor patients have only one copy 
of the defective gene. Some people with beta-Thalassemia 
minor experience mild anemia (Galanello and Origa, 2010) 
and may need to maintain their diets, but in normal case, 
most of the individuals lead a perfectly healthy life and there 
is no need for special treatment. In fact, many patients do 
not know that they are carrying the defective genes, unless 
they have been tested for it. There is mild anemia in the 
patients. Even with this mild anemia, patients often complain 
for weakness and fatigue of varying degrees (Clarke and 
Higgins, 2000).  
Thalassemia minor is caused by defects in the genes 
that make haemoglobin. The type of defective gene is 
responsible for the nature of Thalassemia minor inherited by 
an individual. Beta-Thalassemia minor is caused by the 
reduction or the absence of beta globin synthesis (Thomas, 
2001). Thalassemia patients usually lead a healthy life. 
Some cases of Thalassemia minor have occasionally been 
reported with splenomegaly, mild bone changes, leg ulcers, 
or cholelithiasis. Sometimes in pregnant women, significant 
anemia may develop which requires 1-5 mg/day of folic acid 
and supportive transfusion therapy (Rachmilewitz and 
Giardina, 2011). Some patients have complaints for fatigue. 
Diagnosis of Thalassemia minor can be done by many 
means such as by polymerase chain reaction (PCR) that is 
at molecular level, by performing osmotic fragility test (used 
in this study) and haematological based diagnosis. 
Treatment for Beta Thalassemia minor includes the periodic 
blood transfusions throughout the life of patients, combined 
with iron chelation. Blood transfusions should be given only 
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when required (Nikam et al., 2012). Muhammad et al. 
(2013) found co-infection of diabetes mellitus with HCV and 
HBV. The risk factors linked with hepatocellular carcinoma 
include age, sex, diet, alcohol, and infection with hepatitis B 
virus (HBV) and/or hepatitis C virus (HCV) (Ali et al., 2015) 
that may result in thalassemia patients due to repeated 
blood transfusions. 
Haemoglobin is a protein which has a molecular weight 
of about 68,000 Da (Determann, 1968) and pI at 6.8-7.0 
(Gubbuk et al., 2012). It contains four approximately equal 
polypeptide chains (Gubbuk et al., 2012) which are identical 
in pairs. Several types of haemoglobin are produced in 
normal human developmental stages. These are 
haemoglobin A (Adult haemoglobin) and a subfraction A1, 
haemoglobin A2, fetal haemoglobin and embryonic 
haemoglobin (Muirhead and Perutz, 1963). The amount of 
HbA2 in a normal individual increases 2.5-3.5% of the total 
haemoglobin during the first and a half year of a child’s life 
(Mosca et al., 2009). HbA2 is used as a basis for the 
diagnosis of Thalassemia minor soon after it was discovered 
in 1950s (Kunkel et al., 1957). 
Complete blood count (CBC) test results of 
Thalassemia minor individuals show low Mean corpuscular 
volume (MCV), Mean corpuscular heamoglobin (MCH) 
(Rathod et al., 2007) , the Red cell count is elevated, that is 
>5.0x106 μl and Red cell distribution width (RDW) is less 
17% (Burdick et al., 2009) with the exception that Mean 
corpuscular haemoglobin concentration (MCHC) is normal 
(Hussain et al., 2005). Blood smear shows basophilic 
stippling of erythrocytes (Peter and Rowley, 1976), 
microcytosis with or without mild anemia (O'Donnell and 
Ahuja, 2005). Usually the parasite of malaria (Falciparum 
malaria) grows inside the RBCs of a normal human and 
causes Malaria. But in Thalassemia minor, the patients have 
a protection against Malaria because the RBCs in the 
Thalassemia minor patients are fragile. The cells break 
down when malarial parasite gets inside and the parasite 
stops growing (Jacoby and Youngson, 2005). 
 It has been estimated that the global prevalence of 
Thalassemia minor is at around 1.5% and the countries in 
which Thalassemia minor is most common, which fall in the 
"Thalassemia red belt", include North and South Africa, 
Southern Europe, the Middle East, Southeast Asia, and the 
Far East (Khosa et al., 2015).  It has been estimated that the 
incident rate of Beta Thalassemia minor in the Pakistani 
population has met up to approximately 6% (Usman et al., 
2011). 
 
MATERIALS AND METHODS 
Sample collection 
One hundred blood samples of known Thalassemia 
minor individuals were collected for the study. Blood 
samples were collected by the injection of a new syringe 
each time for each patient. 
Naked-Eye Single TubeRed Cell Osmotic Fragility Test 
(NESTROFT) 
Naked-eye single tube red cell osmotic fragility test 
(NESTROFT) was performed for screening of Beta 
Thalassemia minor which was also chosen by Sunil and his 
colleagues (Gomber and Madan, 1997). 100 sterile test 
tubes were taken containing 4ml 0.36% saline. 50μl blood 
was added in the tubes respectively. The tubes were left 
undisturbed at room temperature for 30mins. The turbidity in 
the tubes was observed in the presence of a tube light 
behind them. Turbidity shows whether the individual is 
Thalassemia minor or Iron deficient. For confirmation, CBC 
was done. 
Complete Blood Count (CBC) Test  
As per the recommendations given by International 
Committee for Standardization in Hematology expert panel, 
complete blood count (CBC) is an initial test for Beta 
Thalassemia minor diagnosis (Clarke and Higgins, 2000). 
Blood sample was collected in a test tube containing an 
anticoagulant (EDTA, sometimes citrate) to prevent it from 
clotting. The blood was shaken vigorously and placed on a 
rack in the analyzer (Sysmex KX-21). The blood 
components were analyzed and the results came out in a 
printed form. Blood counting machines aspirate a very little 
amount of the sample through small tubing. Sensors 
compute the number of cells passing through the tubing, 
and can determine the type of cell. 
 
RESULTS  
The black line behind the test tubes containing blood 
was not clearly visible which indicates positive test (Figure 
1) (Thalassemia trait/Thalassemia minor) due to the turbidity 
of the solution. 
 
 
 
Fig. 1. Naked Eye Single-Tube Red Cell Osmotic Fragility 
(NESTROFT) Test 
 
Significantly low Mean corpuscular volume (MCV) and 
Mean corpuscular hemoglobin (MCH) (Figure 2) was found 
among all individuals with a mean of 64.55fl and 19.60pg 
respectively ( Table 1). MCV value <80fl and MCH value 
<27pg are the significant diagnostic parameters of 
Thalassemia minor. 
The results showed normal RBC count [4.7-6.1 (M), 4.2-
5.4 (F)] in 73.5% individuals and elevated RBC count in 
24.5% individuals. Normal and elevated Red cell count with 
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significantly low MCV and MCH indicates that the individuals 
are Thalassemia minor. 
 
 
 
Fig. 2. Mean values of MCV and MCH 
 
DISCUSSION 
It has been surveyed that Beta Thalassemia minor is 
very common in Pakistan (Khosa et al., 2015). There are a 
number of different procedures available for the detection 
and confirmation of Thalassemia individuals (Nikam et al., 
2012) but most of them are much expensive and are not 
available in every diagnostic laboratory. Keeping these 
problems in mind, we evaluated the accuracy of inexpensive 
methods by known patients. In this study for the detection of 
Thalassemia minor carriers, Osmotic fragility test was 
carried out firstly. 
 
Table 1. RBC count, MCV and MCH ranges in known Thalassemia minor individuals 
RBC Count Mean corpuscular volume (fL) Mean corpuscular haemoglobin (pg) 
No. of samples Range No. of samples Range No. of samples Range 
28 4-4.9 48 61-65 58 15-19 
47 5-5.9 29 66-70 42 20-24 
22 6-6.9 14 56-60 - - 
3 >7 9 71-75 - - 
Total: 100 - Total: 100 Mean: 64.55 100 Mean: 19.60 
Turbidity appeared in all tubes which means all the 
individuals were Thalassemia minor. It was confirmed by the 
CBC test that the RCC range in these patients was normal 
(73.5% of the total samples) and elevated (24.5%). By these 
results, we can differentiate Thalassemia minor from other 
types of anemia. In a previous study in Egypt, El-Beshlawy 
et al. (2007) found sensitivity and specificity of one tube 
fragility test as 87% and 34.1% respectively. The MCV and 
MCH ranges were significantly lower in cases of 
Thalassemia minor. All patients in this study had MCV 
values between 56-75fl with a mean of 64.55fl and MCH 
values between 15-24pg with a mean of 19.60pg. The 
normal values for MCV and MCH are 80-99 fl and 27 to 31 
pg/cell respectively. Hence elevated RCC, MCV < 80fl and 
MCH <27pg are outstanding diagnostic criterion along with 
positive NESTROFT test in detecting Thalassemia carriers. 
Yamsri et al. (2011) showed MCV less than 80 fl and MCH 
less than 27 pg in Thalassemia carriers. Hb electrophoresis 
facility is lacking at many places in Pakistan. Red cell indices 
obtained from electronic counters can be reliably used in 
diagnosing Thalassemia. CBC provided by a routine 
automated blood counter is a major contributor for large-
scale screening and convenient detection of carriers. They 
are cheap and easily reachable by individuals who are not 
competent in hematology. 
 
CONCLUSION 
Poverty in Pakistan has limited the population to get 
treatments for many diseases whose tests and medications 
are much expensive and unaffordable. As the tests for 
detecting Thalassemia minor at molecular level are costly for 
a lower-class individual, cheap tests such as NESTROFT 
and CBC are recommended which give an idea whether the 
patient has Thalassemia minor or not. The main purpose of 
this study is to give awareness to our community about 
Thalassemia minor and its cheap diagnosis which can 
differentiate it from other types of anemia. Various 
awareness camps and seminars should be arranged. 
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